Felbamate

Seminars in Pediatric Neurology

Volumn 4, Issue 1, 1997, Pages 3-8

  Bourgeois, B F D ^a  

^a ST LOUIS CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; FELBAMATE; PHENYTOIN; PLACEBO; VALPROIC ACID;

ANOREXIA; APLASTIC ANEMIA; ARTICLE; BONE MARROW APLASIA; CLINICAL TRIAL; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG METABOLISM; EPILEPSY; GASTROINTESTINAL TOXICITY; HEADACHE; HUMAN; LENNOX GASTAUT SYNDROME; LIVER TOXICITY; PHARMACOKINETICS; SOMNOLENCE;

EID: 0030934966     PISSN: 10719091     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1071-9091(97)80003-4     Document Type: Article

References (27)

1. Swinyard EA Sofia RD Kupferberg HJ Comparative anticonvulsant activity and neurotoxicity of felbamate and four prototype antiepileptic drugs in mice and rats Epilepsia 27 1986 27 34
2. White HS Wolf HH Swinyard EA A neuropharmacological evaluation of felbamate as a novel anticonvulsant Epilepsia 33 1992 564 572
3. Lockard JS Levy RH Moore DF Drug alteration of seizure cyclicity Wolf P Dam M Janz D XVIth Epilepsy International Symposium. Advances in Epileptology, vol 16 1987 Raven New York NY 725 732
4. White HS Harmsworth WL Sofia RD Felbamate modulates the strychnine-insensitive glycine receptor Epilepsy Res 20 1995 41 48
5. A receptor system Epilepsia 32 1991 389 391
6. A receptors Ann Neurol 35 1994 229 234
7. 14C]felbamate in healthy men Epilepsia 31 1990 642
8. Adusumalli VE Wichmann JK Kucharczyk N Drug concentration in human brain tissue samples from epileptic patients treated with felbamate Drug Metab Dispos 22 1994 168 170
9. Perhach JL Weliky I Newton JJ Felbamate Meldrum BS Porter RJ New Anticonvulsant Drugs 1986 Libbey London, England; Paris, France 117 123
10. Ward DL Shumaker RC Comparative bioavailability of felbamate in healthy men Epilepsia 31 1990 642
11. Sachdeo RC Narang-Sachdeo SK Howard JR Steady-state pharmacokinetics and dose proportionality of felbamate after oral administration of 1200, 2400, and 3600 mg/day of felbamate Epilepsia 34 1993 80
12. Wagner ML Graves NM Leppik IE The effect of felbamate on valproate disposition Epilepsia 32 1991 15
13. TM (felbamate) Epilepsia 33 suppl 3 1992 84
14. Hooper WD Franklin ME Glue P Effect of felbamate on valproic acid disposition in healthy volunteers: Inhibition of β-oxidation Epilepsia 37 1996 91 97
15. Howard JR Dix RK Shumaker RC Effect of felbamate on carbamazepine pharmacokinetics Epilepsia 33 suppl 3 1992 84 85
16. Wagner ML Graves NM Marineau K Discontinuation of phenytoin and carbamazepine in patients receiving felbamate Epilepsia 32 1991 398 406
17. Ward DL Wagner ML Perhach JL Felbamate steady-state pharmacokinetics during co-administration of valproate Epilepsia 32 suppl 3 1991 8
18. Bourgeois B Leppik IE Sackellares JC Felbamate: a double-blind controlled trial in patients undergoing presurgical evaluation of partial seizures Neurology 43 1993 693 696
19. Sachdeo R Kramer LD Rosenberg A Felbamate monotherapy: Controlled trial in patients with partial onset seizures Ann Neurol 32 1992 386 392
20. Faught E Sachdeo RC Remler MP Felbamate monotherapy for partial-onset seizures: An active-control trial Neurology 43 1993 688 692
21. The felbamate study group in Lennox-Gastaut syndrome: Efficacy of felbamate in childhood epileptic encephalopathy (Lennox-Gastaut syndrome) N Engl J Med 328 1993 29 33
22. Devinski O Kothari M Rubin R Felbamate for absence seizures Epilepsia 33 suppl 3 1992 84
23. Sachdeo RC Murphy JV Kamin M Felbamate in juvenile myoclonic epilepsy Epilepsia 33 suppl 3 1992 118
24. Harden CL Trifiletti R Kutt H Felbamate levels in patients with epilepsy Epilepsia 37 1996 280 283
25. Wallace Laboratories, Inc: Data on file. Cranbury NJ
26. O'Neil MG Perdun CS Wilson MB Felbamate-associated fatal acute hepatic necrosis Neurology 46 1996 1457 1459
27. Bryant AE Dreifuss FE Valproic acid hepatic fatalities. III. U.S. experience sience 1986 Neurology 46 1996 465 469